Literature DB >> 10813210

Measurement of quality of life in cystic fibrosis.

A L Quittner1.   

Abstract

Considerable progress has been made over the past 2 decades in defining and measuring health-related quality of life (QOL), and there is a growing recognition that these measures provide unique information about the impact of a chronic illness and its treatment. For patients with cystic fibrosis (CF), health-related QOL measures enable researchers and clinicians to determine the effects of clinical interventions on several aspects of daily living (psychological, emotional, social) that are not reflected in typical health indicators, eg, pulmonary functioning scores. Three types of health-related QOL measures have been developed: 1) utility measures, 2) health profiles, and 3) disease-specific measures. The purpose of each type of health-related QOL measure is described, and its application to patients with CF is reviewed. Although important descriptive information has been obtained from utility measures, eg, the Quality of Well-Being Scale, and health profiles, eg, the Nottingham Health Profile, both of these instruments have serious limitations. Disease-specific measures, similar to those developed for children and adults with asthma, seem to hold the greatest promise for advancing our understanding of the impact of CF on daily life and for evaluating the effectiveness of new clinical interventions. The Cystic Fibrosis Questionnaire is the only published disease-specific measure of health-related QOL for children, adolescents, and adults with CF. Its psychometric properties are briefly reviewed, and directions for future research are suggested.

Entities:  

Mesh:

Year:  1998        PMID: 10813210     DOI: 10.1097/00063198-199811000-00003

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  17 in total

1.  The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument.

Authors:  Kerstin Wenninger; Pierre Aussage; Ulrich Wahn; Doris Staab
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

2.  Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.

Authors:  Bernadette Henry; Pierre Aussage; Cécile Grosskopf; Jean-Marie Goehrs
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

3.  Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

Authors:  N Lechtzin; N West; S Allgood; E Wilhelm; U Khan; N Mayer-Hamblett; M L Aitken; B W Ramsey; M P Boyle; P J Mogayzel; C H Goss
Journal:  Contemp Clin Trials       Date:  2013-09-19       Impact factor: 2.226

4.  Health-related quality of life across pediatric chronic conditions.

Authors:  Lisa M Ingerski; Avani C Modi; Korey K Hood; Ahna L Pai; Meg Zeller; Carrie Piazza-Waggoner; Kimberly A Driscoll; Marc E Rothenberg; James Franciosi; Kevin A Hommel
Journal:  J Pediatr       Date:  2010-02-01       Impact factor: 4.406

5.  Initial development and pilot testing of observer-reported outcomes (ObsROs) for children with cystic fibrosis ages 0-11years.

Authors:  T C Edwards; J Emerson; A Genatossio; S McNamara; C Goss; D L Patrick; F Onchiri; M Rosenfeld
Journal:  J Cyst Fibros       Date:  2018-02-01       Impact factor: 5.482

Review 6.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

Review 7.  Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.

Authors:  Janice Abbott; Louise Gee
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 8.  Patient-reported outcomes in cystic fibrosis.

Authors:  Christopher H Goss; Alexandra L Quittner
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

9.  Evaluating the protective role of racial identity in children with sickle cell disease.

Authors:  Crystal S Lim; Josie S Welkom; Lindsey L Cohen; Ifeyinwa Osunkwo
Journal:  J Pediatr Psychol       Date:  2012-05-07

10.  Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R.

Authors:  Anne Schmidt; Kerstin Wenninger; Nadja Niemann; Ulrich Wahn; Doris Staab
Journal:  Health Qual Life Outcomes       Date:  2009-12-02       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.